Inovio Pharmaceuticals, Inc. (INO)
1.37
+0.07
(+5.38%)
USD |
NASDAQ |
May 18, 11:01
Inovio Pharmaceuticals EPS Diluted (Quarterly) : -0.2848 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| ADMA Biologics, Inc. | 0.1889 |
| Agenus, Inc. | 1.023 |
| Vaxart, Inc. | 0.0214 |
| Allogene Therapeutics, Inc. | -0.1773 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.68M |
| Total Expenses (Quarterly) | 19.68M |
| Enterprise Value | 77.97M |
| Earnings Yield | -124.7% |
| Normalized Earnings Yield | -120.16 |